Considering that loss of PTEN results in lower insulin resistance [131] and lipogenesis [132], which is responsible for tumor microenvironment establishment [133], NEDD4 reprograms metabolic status and tumor progression through PTEN ubiquitination (Figure 2B). Here, INS is linked to neoplasm.